# Safety Study of A-101 Topical Solution for the Treatment of Common Warts

> **NCT03812510** · PHASE3 · COMPLETED · sponsor: **Aclaris Therapeutics, Inc.** · enrollment: 426 (actual)

## Conditions studied

- Common Wart

## Interventions

- **DRUG:** A-101

## Key facts

- **NCT ID:** NCT03812510
- **Lead sponsor:** Aclaris Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-07
- **Primary completion:** 2019-11-27
- **Final completion:** 2019-12-20
- **Target enrollment:** 426 (ACTUAL)
- **Last updated:** 2020-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03812510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03812510, "Safety Study of A-101 Topical Solution for the Treatment of Common Warts". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03812510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*